SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-025562
Filing Date
2022-09-27
Accepted
2022-09-27 16:30:52
Documents
1
Period of Report
2022-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166431062499276.html 4  
1 FORM 4 wf-form4_166431062499276.xml 4 5182
  Complete submission text file 0001628280-22-025562.txt   6502
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Hart Jayne B. (Reporting) CIK: 0001519749 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 221271481